• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. LAGB SYSTEM 10CM; ADJUSTABLE GASTRIC BAND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. LAGB SYSTEM 10CM; ADJUSTABLE GASTRIC BAND Back to Search Results
Model Number B-2220
Medical Device Problem Code Device Slipped (1584)
Health Effect - Clinical Codes Dysphagia/ Odynophagia (1815); Regurgitation (2259)
Date of Event 01/16/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Unknown taper.Medwatch sent to fda on 03/01/2017.The reporter of the event was asked to return the product for analysis.To date, apollo has not received the device.If returned, visual examination may confirm or determine another taper type associated with this event.Device labeling addresses the reported event as follows: precautions: over-dissection of the stomach during placement may result in slippage or erosion of the band and require reoperation.Adverse events: it is important to discuss all possible complications and adverse events with your patient.Complications which may result from the use of this product include the risks associated with the medications and methods utilized in the surgical procedure, the risks associated with any surgical procedure and the patient's degree of intolerance to any foreign object implanted in the body.Ulceration, gastritis, gastroesophageal reflux, heartburn, gas bloat, dysphagia, dehydration, constipation, and weight regain have been reported after gastric restriction procedures.Band slippage and/or pouch dilatation can occur.Gastroesophageal reflux, nausea and/or vomiting with early or minor slippage may be successfully resolved by band deflation in some cases.More serious slippages may require surgery to reposition and/or remove the band.Immediate re-operation to remove the band is indicated if there is total stoma-outlet obstruction that does not respond to band deflation or if there is abdominal pain.Warnings: patients should be advised that the lap-band ap system is a long-term implant.Explant (removal) and replacement surgery may be indicated at any time.Medical management of adverse reactions may include explantation.Revision surgery for explantation and replacement may also be indicated to achieve patient satisfaction.
 
Event or Problem Description
Reported as: the patient's lap-band system was explanted due to "gastric prolapse, gerd, dysphagia.".
 
Additional Manufacturer Narrative
Taper ii.Device evaluation summary: the device was returned to the apollo device analysis laboratory on 21/feb/2017.A visual examination was performed and determined the connector type to be taper ii.Needle marks and brown discoloration was noted on the port septum.Scratch marks were noted on one port hole and on the port base.Port base was noted to be discolored, slight yellow in color.The port tubing was noted to be discolored, and was light brown in appearance.The lap-band ring was noted to be in two pieces, separation was near the buckle.The buckle was noted to be partially separated.White particles were noted on the outer surface of the band shell.Slight brown discoloration was noted on the belt and the band tubing.An air leak test was not feasible as the band ring was in two separate pieces.A fill inspection test was performed and no blockage was noted.Under microscopic analysis, the band, end of the port and band tubing were noted to have surgical cuts, consistent with removal of the device.Also under microscopic analysis, multiple needle punctures were noted on the port septum.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAGB SYSTEM 10CM
Common Device Name
ADJUSTABLE GASTRIC BAND
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s capitol of texas hwy
bldg 1, ste 300
austin TX 78746
MDR Report Key6368804
Report Number3006722112-2017-00064
Device Sequence Number13563788
Product Code LTI
UDI-Device Identifier10811955020169
UDI-Public(01)10811955020169(11)030228(17)050227(10)559397
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
P000008
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2003
Device Explanted Year2017
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Physician
Device Expiration Date02/27/2005
Device Model NumberB-2220
Device Catalogue NumberB-2220
Device Lot Number559397
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/21/2017
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 02/02/2017
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date03/01/2017
Supplement Report FDA Received Date06/07/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age54 YR
Patient Weight163
-
-